龙寿丹治疗脑梗塞临床疗效观察（Clinical observation of Long Shoudan in the treatment of cerebral infarction）.docVIP

下载本文档

1
0
约6.9千字
约 6页
2017-09-02 发布于河南
举报
版权申诉

龙寿丹治疗脑梗塞临床疗效观察（Clinical observation of Long Shoudan in the treatment of cerebral infarction）.doc

1、本文档共6页，可阅读全部内容。
2、原创力文档（book118）网站文档一经付费（服务费），不意味着购买了该文档的版权，仅供个人/单位学习、研究之用，不得用于商业用途，未经授权，严禁复制、发行、汇编、翻译或者网络传播等，侵权必究。
3、本站所有内容均由合作方或网友上传，本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺！文档内容仅供研究参考，付费前请自行鉴别。如您付费，意味着您自己接受本站规则且自行承担风险，本站不退款、不进行额外附加服务；查看《如何避免下载的几个坑》。如果您已付费下载过本站文档，您可以点击这里二次下载。
4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等，请点击“版权申诉”（推荐），也可以打举报电话：400-050-0827(电话支持时间：9:00-18:30)。
5、该文档为VIP文档，如果想要下载，成为VIP会员后，下载免费。
6、成为VIP后，下载本文档将扣除1次下载权益。下载后，不支持退款、换文档。如有疑问请联系我们。
7、成为VIP后，您将拥有八大权益，权益包括：VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
8、VIP文档为合作方或网友上传，每下载1次，网站将根据用户上传文档的质量评分、类型等，对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档

龙寿丹治疗脑梗塞临床疗效观察（Clinical observation of Long Shoudan in the treatment of cerebral infarction）

龙寿丹治疗脑梗塞临床疗效观察（Clinical observation of Long Shoudan in the treatment of cerebral infarction） Clinical observation of Long Shoudan in the treatment of cerebral infarction Update Date: 2011-04-11 Click: Xu Hui factory, Feng Meixiang, Li Songkui, Jia Shutang Our department Shandong Jining Huaneng biotechnology limited production of Chinese medicine preparation Longstand, 30 cases of patients with acute cerebral infarction treatment, obtain satisfactory curative effect, and no obvious side effects. It is reported as follows. 1 general information 60 patients with acute cerebral infarction confirmed by head CT scan were randomly divided into two groups. The treatment group of 30 cases, male 17 cases, female 13 cases, age 45~73 years old, average 65.5 years old, 30 cases of the control group, male 18 cases, female 12 cases, age 47~71 years old, average 62.8 years old. According to the 1986 Second National Conference on cerebrovascular disease through stroke patients with neurological deficit score 1 standard for evaluation, the treatment group with mild (0 to 15) in 21 cases, moderate (16 to 30) in 5 cases, severe (31 to 45) in 4 cases; control group, 22 cases were mild, 4 moderate cases and 4 severe cases. 2 treatment The treatment group oral Longstand 2 tablets, 3 times /d, before meals, a total of 21 d patients in control group were treated with Venoruton 0.2, 3 times /d, before meals, a total of 21 d, two groups of other symptomatic treatment and adjuvant therapy were the same, without the use of vasodilator drugs and other anticoagulant drugs. 3 observation index The changes of hemorheology, blood routine, urine routine, liver and kidney function, blood coagulation time and clinical signs were observed before and after treatment. If there is any adverse reaction during the treatment, record it promptly. If severe adverse events are recorded, the treatment is recorded. 4 Efficacy Evaluation and statistical methods According to the evaluation standard of stroke patient